J. Goldman & Co LP lifted its holdings in shares of Rafael Holdings, Inc. (NYSE:RFL – Get Rating) by 14.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 783,156 shares of the company’s stock after acquiring an additional 97,700 shares during the quarter. J. Goldman & Co LP owned 3.76% of Rafael worth $1,966,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of RFL. UBS Group AG grew its holdings in Rafael by 143.7% during the first quarter. UBS Group AG now owns 13,648 shares of the company’s stock valued at $35,000 after purchasing an additional 8,047 shares during the period. Fisher Asset Management LLC bought a new position in Rafael during the first quarter valued at $55,000. Atria Wealth Solutions Inc. bought a new position in Rafael during the first quarter valued at $81,000. PDT Partners LLC bought a new position in Rafael during the fourth quarter valued at $117,000. Finally, IndexIQ Advisors LLC bought a new position in Rafael during the first quarter valued at $367,000. 43.19% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Rafael
In related news, Chairman Howard S. Jonas purchased 3,225,806 shares of the business’s stock in a transaction dated Wednesday, July 6th. The stock was purchased at an average cost of $1.86 per share, with a total value of $5,999,999.16. Following the completion of the acquisition, the chairman now directly owns 3,338,367 shares of the company’s stock, valued at $6,209,362.62. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 7.90% of the company’s stock.
Rafael Price Performance
Rafael (NYSE:RFL – Get Rating) last announced its quarterly earnings data on Tuesday, June 14th. The company reported ($0.28) earnings per share for the quarter. Rafael had a negative net margin of 3,757.51% and a negative return on equity of 63.38%. The firm had revenue of $0.88 million for the quarter.
Rafael Holdings, Inc holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
- Get a free copy of the StockNews.com research report on Rafael (RFL)
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
Receive News & Ratings for Rafael Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rafael and related companies with MarketBeat.com's FREE daily email newsletter.